SLC39A4, solute carrier family 39 member 4, 55630

N. diseases: 87; N. variants: 12
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 GeneticVariation disease BEFREE About half of the missense AE-causing mutations occur within the large N-terminal extracellular domain (ECD), and our previous study has shown that ZIP4-ECD is crucial for optimal zinc uptake but the underlying mechanism has not been clarified. 31164399 2019
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 GeneticVariation disease BEFREE We report a case of AE presenting with only periorificial and acral dermatitis in which genetic testing revealed two novel compound heterozygous missense mutations for SLC39A4. 25780817 2016
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 Biomarker disease GENOMICS_ENGLAND Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes. 27604308 2016
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 GeneticVariation disease BEFREE The possible functional effect of the Leu372Val substitution, together with two pathological mutations at the same codon (Leu372Pro and Leu372Arg) that cause acrodermatitis enteropathica (a disease phenotype characterized by extreme zinc deficiency), was investigated by transient overexpression of human ZIP4 protein in HeLa cells. 24586184 2014
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 Biomarker disease BEFREE Conditional knockout of the intestinal zinc transporter Zip4 (Slc39a4) in mice creates a model of the lethal human genetic disease acrodermatitis enteropathica (AE). 24015258 2013
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 Biomarker disease BEFREE These studies strongly suggest that wasting and lethality in acrodermatitis enteropathica patients reflects the loss-of-function of the intestine zinc transporter ZIP4, which leads to abnormal Paneth cell gene expression, disruption of the intestinal stem cell niche, and diminished function of the intestinal mucosa. 22737083 2012
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 GermlineCausalMutation disease ORPHANET We describe a novel homozygous mutation, 1191insC, in SLC39A4 in a patient from Sierra Leone and suggest that AE should be considered within the differential diagnosis for acrodermatitis in children from Sierra Leone. 22082465 2012
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 GermlineCausalMutation disease ORPHANET Clinical utility gene card for: acrodermatitis enteropathica. 22166942 2012
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 GeneticVariation disease BEFREE We describe a novel homozygous mutation, 1191insC, in SLC39A4 in a patient from Sierra Leone and suggest that AE should be considered within the differential diagnosis for acrodermatitis in children from Sierra Leone. 22082465 2012
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 GeneticVariation disease BEFREE Acrodermatitis enteropathica: a novel SLC39A4 gene mutation found in a patient with an early-onset. 21906148 2012
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 GeneticVariation disease BEFREE Recent research revealed that mutations in the SLC39A4 gene are responsible for acrodermatitis enteropathica. 20300938 2010
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 GeneticVariation disease BEFREE Congenital zinc deficiency from mutations of the SLC39A4 gene as the genetic background of acrodermatitis enteropathica. 21165302 2010
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 Biomarker disease BEFREE Novel proteolytic processing of the ectodomain of the zinc transporter ZIP4 (SLC39A4) during zinc deficiency is inhibited by acrodermatitis enteropathica mutations. 18936158 2009
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 GeneticVariation disease BEFREE In 2002, both we and others identified the AE SLC39A4 gene located at 8q24.3, and described the first causative mutations for the disease. 19370757 2009
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 Biomarker disease CTD_human The human Zip4 gene (Slc39a4) is mutated in the rare recessive genetic disorder of zinc metabolism acrodermatitis enteropathica, but the physiological functions of Zip4 are not well understood. 17483098 2007
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 GeneticVariation disease BEFREE Mutations in the SLC39A4 gene are responsible for acrodermatitis enteropathica. 16889938 2006
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 Biomarker disease BEFREE Recently, the basic defect in AE was found to lie in SLC39A4. 16714095 2006
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 Biomarker disease CTD_human The ZIP5 gene encodes a protein closely related to ZIP4, a zinc transporter mutated in the human genetic disorder acrodermatitis enteropathica. 15358787 2004
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 Biomarker disease CTD_human To investigate the effects of these mutations on function of the Zip4 transporter, we introduced six AE-associated missense mutations into the orthologous mouse ZIP4 gene for functional expression in cultured cells. 14709598 2004
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 GeneticVariation disease UNIPROT Complete sequencing and characterization of 21,243 full-length human cDNAs. 14702039 2004
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 GeneticVariation disease UNIPROT SLC39A4 mutations have been demonstrated in several acrodermatitis enteropathica families, and in this study we have examined two Japanese acrodermatitis enteropathica families for SLC39A4 mutations. 12787121 2003
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 GermlineCausalMutation disease ORPHANET SLC39A4 mutations have been demonstrated in several acrodermatitis enteropathica families, and in this study we have examined two Japanese acrodermatitis enteropathica families for SLC39A4 mutations. 12787121 2003
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 GeneticVariation disease BEFREE SLC39A4 mutations have been demonstrated in several acrodermatitis enteropathica families, and in this study we have examined two Japanese acrodermatitis enteropathica families for SLC39A4 mutations. 12787121 2003
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 GeneticVariation disease BEFREE This study brings to 21 the number of reported SLC39A4 mutations in AE families. 12955721 2003
CUI: C0221036
Disease: Acrodermatitis enteropathica
Acrodermatitis enteropathica
1.000 GeneticVariation disease BEFREE The chromosomal location and expression of SLC39A4, together with mutational analysis of eight families affected with acrodermatitis enteropathica, suggest that SLC39A4 is centrally involved in the pathogenesis of this condition. 12068297 2002